MPM BioVentures 2014 LLC's Net Worth
$262 Million
Who is MPM BioVentures 2014 LLC?
MPM BioVentures 2014 LLC has an estimated net worth of $262 Million. This is based on reported shares across multiple companies, which include iTeos Therapeutics, Inc., Entrada Therapeutics, Inc., Repare Therapeutics Inc., Harpoon Therapeutics, Inc., TCR2 THERAPEUTICS INC., Werewolf Therapeutics, Inc., and Oncorus, Inc..
SEC CIK
MPM BioVentures 2014 LLC's CIK is 0001765021
Past Insider Trading and Trends
2020 was MPM BioVentures 2014 LLC's most active year for acquiring shares with 24 total transactions. MPM BioVentures 2014 LLC's most active month to acquire stocks was the month of June. 2021 was MPM BioVentures 2014 LLC's most active year for disposing of shares, totalling 100 transactions. MPM BioVentures 2014 LLC's most active month to dispose stocks was the month of August. 2019 saw MPM BioVentures 2014 LLC paying a total of $14,121,250.25 for 8,058,849 shares, this is the most they've acquired in one year. In 2021 MPM BioVentures 2014 LLC cashed out on 59,972,557 shares for a total of $47,182,349.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Entrada Therapeutics, Inc. (TRDA) Snapshot price: $14.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.43M |
$20.00 |
—
| 4.43M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.14% | -4.67K |
$20.16 | -$94,075.07 | 3.22M |
Scheduled
|
Apr 13 - Apr 15
| ||
Form 4
| -0.40% | -12.80K |
$23.15 | -$296,261.00 | 3.23M |
Scheduled
|
Apr 9 - Apr 12
| ||
Form 4
| -5.35% | -183.05K |
$20.00 | -$3,661,020.00 | 3.24M |
Scheduled
|
Feb 10
| ||
Form 4
| -2.61% | -91.70K |
$20.06 | -$1,839,336.84 | 3.42M |
Scheduled
|
Feb 5 - Feb 9
| ||
Form 4
| -3.30% | -120.07K |
$20.22 | -$2,427,558.45 | 3.51M |
Scheduled
|
Feb 2 - Feb 4
| ||
Form 4
| -16.56% | -721.19K |
$20.02 | -$14,441,349.42 | 3.63M |
Scheduled
|
Jan 25 - Jan 27
| ||
Form 4
| -3.76% | -170.10K |
$22.51 |
—
| 4.35M |
Scheduled
|
Jan 20 - Jan 22
| ||
Form 4
| +1,304.83% | 4.2M |
$9.58 | -$21,336.00 | 4.52M |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $9.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.08% | -146.69K |
$42.58 | -$6,246,049.63 | 2.74M |
Jan 4 - Jan 5
| |||
Form 4
| -1.70% | -49.83K |
$33.73 | -$1,680,611.12 | 2.89M |
Scheduled
|
Dec 3 - Dec 7
| ||
Form 4
| -1.40% | -83.52K |
$34.63 | -$2,878,562.19 | 5.88M |
Scheduled
|
Nov 30 - Dec 2
| ||
Form 4
| -0.76% | -23.05K |
$35.18 | -$810,765.76 | 3.02M |
Scheduled
|
Nov 26 - Nov 29
| ||
Form 4
| -2.97% | -93.13K |
$36.61 | -$2,835,263.01 | 3.04M |
Scheduled
|
Nov 17 - Nov 24
| ||
Form 4
| -0.54% | -17.10K |
$27.45 | -$469,309.06 | 3.13M |
Scheduled
|
Oct 15 - Oct 18
| ||
Form 4
| -1.77% | -56.77K |
$27.21 | -$1,544,473.66 | 3.15M |
Scheduled
|
Oct 12 - Oct 14
| ||
Form 4
| -1.59% | -51.99K |
$27.23 | -$1,415,546.20 | 3.21M |
Scheduled
|
Oct 7 - Oct 11
| ||
Form 4
| -0.84% | -27.57K |
$27.05 | -$745,524.66 | 3.26M |
Scheduled
|
Oct 1 - Oct 4
| ||
Form 4
| -0.65% | -21.51K |
$27.00 | -$580,662.00 | 3.29M |
Scheduled
|
Sep 28 - Sep 30
| ||
Form 4
| -1.59% | -53.47K |
$27.76 | -$1,484,415.72 | 3.31M |
Scheduled
|
Sep 23 - Sep 27
| ||
Form 4
| -1.00% | -33.93K |
$27.50 | -$933,030.21 | 3.36M |
Scheduled
|
Sep 21 - Sep 22
| ||
Form 4
| -2.62% | -91.25K |
$28.38 | -$2,590,097.17 | 3.4M |
Scheduled
|
Sep 16 - Sep 20
| ||
Form 4
| -1.29% | -45.66K |
$27.70 | -$1,264,909.69 | 3.49M |
Scheduled
|
Sep 14 - Sep 15
| ||
Form 4
| -1.60% | -57.64K |
$28.32 | -$1,632,261.44 | 3.53M |
Scheduled
|
Sep 9 - Sep 13
| ||
Form 4
| -0.68% | -73.91K |
$28.92 | -$1,235,644.04 | 10.83M |
Scheduled
|
Sep 7 - Sep 8
| ||
Form 4
| -0.00% | -119.00 |
$29.99 | -$3,568.81 | 3.67M |
Scheduled
|
Apr 9
| ||
Form 4
| -0.55% | -40.76K |
$31.00 | -$777,342.98 | 7.32M |
Scheduled
|
Apr 7 - Apr 8
| ||
Form 4
| +63.86% | 3.71M |
$19.00 | $3,040,000.00 | 9.51M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Repare Therapeutics Inc. (RPTX) Snapshot price: $7.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3M |
$20.00 |
—
| 3M |
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TCR2 THERAPEUTICS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.16M |
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +1,967.80% | 3.85M |
$15.00 |
—
| 4.05M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||